Just over two years after establishing desmoidtumors.com, the drugmaker is teaming with Jennifer Fisher to empower patients.
FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes As a rapid-acting insulin, Merilo ...
SpringWorks Therapeutics and Jewelry Designer Jennifer Fisher Team Up to Encourage People with Desmoid Tumors to Take Action ... PR and communications teams face. For 70 years, PR Newswire has ...
SpringWorks continues to advance its product pipeline, with ongoing enrollment for desmoid tumors treatment ... What challenges could SpringWorks face in the competitive rare disease market?
SpringWorks continues to advance its product pipeline, with ongoing enrollment for desmoid tumors treatment ... What challenges could SpringWorks face in the competitive rare disease market? The rare ...
SpringWorks Therapeutics (SWTX) and Jennifer Fisher are collaborating to increase understanding of desmoid tumors as well as to encourage ...
“We are very pleased with the strong execution of OGSIVEO in 2024 and believe that we are still in the early stages of realizing the full potential of our opportunity to serve the desmoid tumor ...
“We are very pleased with the strong execution of OGSIVEO in 2024 and believe that we are still in the early stages of realizing the full potential of our opportunity to serve the desmoid tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results